Impact of race on diagnosis and management of cutaneous toxicities from immune checkpoint inhibitors

Published: 1 October 2020| Version 1 | DOI: 10.17632/m689r3v4r3.1
Contributors:
Leah Thompson,
Catherina Pan,
Michael Chang,
Nira Krasnow,
Steven Chen,
Amy Blum

Description

Study flow diagram showing process of selecting patients receiving immune checkpoint inhibitors with confirmed cirAE diagnoses

Files